Staining pattern and clinicopathological features of Epstein-Barr Virus, Latent Membrane protein 1 expression in patients with Gastric carcinoma in Lake zone, Tanzania

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Infectious agents such as the Epstein-Barr virus are responsible for 10% of gastric carcinomas worldwide. The lake zone in Tanzania lies in an Epstein-Barr virus-endemic (EBV) region, and the contribution of EBV-related gastric cancers has not yet been established. Therefore, this study aims to investigate the prevalence and clinicopathological features of EBV-related gastric carcinoma at Bugando Medical Center. Methods This was a laboratory-based, retrospective cross-sectional study conducted at Bugando Medical Center. Latent membrane protein-1, stained on formalin-fixed paraffin-embedded (FFPE) tissue blocks, to determine the prevalence and staining pattern of EBV-associated Gastric cancers. Data was entered and cleaned in Excel and then analyzed using STATA version 15. The chi-square tests were used to assess associations, with logistic regression used to control confounders, at a significance level of p < 0.05. Results A total of 119 cases were evaluated, with 70 (58.8%) males and 49 (41.2%) females. The prevalence of LMP-1 overexpression was N(40.3%). LMP-1 positive cases were associated with increased age above 60years, and diffuse histological type. Patients aged 60 years and above had an OR = 0.17 ( p = 0.018) of testing LMP-1 positive, and it was statistically significant. Diffuse carcinoma type was significantly associated with increased odds of LMP-1 positivity (OR = 31.39, p = 0.002). The expression pattern was predominantly nuclear in N (77.1%), while N (22.9%) were nuclear and cytoplasmic. Conclusions Gastric carcinoma in our setting showed a high level of LMP-1 overexpression. These findings suggest that all patients with advanced age and diffuse histological type should be screened for LMP-1 overexpression as a predictive marker for targeted therapy and favorable prognostication.

Article activity feed